Absci | Investor Presentation Deck | 42 slides · page 19 of 42
The slide demonstrates that Variant A* shows higher potency than the wild-type trastuzumab in both binding and ADCC assays.
Pitch deck · traction · show_traction · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 chart 2/2 image 1/1 legend 1/1 paragraph 1/1 title 1/1
Components 7
primary line line illustration legend paragraph headline
Tools 1
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.